Part-Time Korean-Speaking Research Interventionist RN
Phase2 Technology
Philadelphia (Philadelphia County)
Hybrid
USD 40,914 - 58,272
Part time
14 days+
Application generator
Turn this role into an interview — a resume and cover letter built around what this employer wants.
Get past ATS filters
Job summary
A well-known technology company is seeking a part-time Research Interventionist (Korean-speaking RN) to conduct research interventions in the School of Nursing. The role involves engaging participants in chat, managing communications, and supporting recruitment efforts. To qualify, candidates must hold a current RN license in the U.S., be fluent in Korean and English, and possess strong communication skills. This position offers flexibility in working hours and is expected to continue until August 2025.
Qualifications
Current RN license within the U.S.
Fluency in Korean and English (both spoken and written).
Strong interpersonal and communication skills.
Basic proficiency in Zoom, MS Office, Microsoft Teams.
Ability to work flexible hours according to participants' schedules.
Responsibilities
Conduct weekly interventions with participants via chat in Simplified Korean or English.
Maintain a research diary, manage communications for participant payments and Fitbit distribution.
Engage in recruitment activities to support the study.
Skills
Fluency in Korean
Strong interpersonal skills
Basic proficiency in Zoom
Basic proficiency in MS Office
Basic proficiency in Microsoft Teams
Education
Current Registered Nurse (RN) license
Job description
A well-known technology company is seeking a part-time Research Interventionist (Korean-speaking RN) to conduct research interventions in the School of Nursing. The role involves engaging participants in chat, managing communications, and supporting recruitment efforts. To qualify, candidates must hold a current RN license in the U.S., be fluent in Korean and English, and possess strong communication skills. This position offers flexibility in working hours and is expected to continue until August 2025.